Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(4-Methylphenyl)butanoic acid is a type of organic compound that belongs to the class of organic compounds called fatty acids. It is an activator of chloride channels, which leads to an increase in the permeability of the cell membrane. 3-(4-Methylphenyl)butanoic acid also has an inhibitory effect on tyrosinase, which is an enzyme that catalyzes the conversion of tyrosinase to melanin. This product may be used as a supplement or medicine for Alzheimer's disease and other neurological disorders. 3-(4-Methylphenyl)butanoic acid is levorotatory and can be found in butanoic acid, isopropyl, and c1-6 alkyl.</p>

<p>Imidazo[1,2-a]pyridine-2-carboxamide (IPC) is a nematicide that belongs to the class of imidazopyridine. It has been shown to have a high efficacy against nematodes in the soil and in plants. This compound has an elemental analysis that shows the fluorine content is at 1%. IPC has a long-chain alkynyl group and phenyl group, which indicates its chemical structures. The diffraction pattern of IPC shows that it is a polymorph form with two different crystalline forms. One of these forms can be seen as a solid and the other as a powder.<br>IPC binds to nuclear receptors on the surface of nematodes and causes them to die from dehydration and lack of oxygen.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-Acetyl-2-hydroxybenzonitrile (5AHB) is a fluorophore that has been used as an exploratory reagent in photochemistry and fluorescence. This compound is a radical mechanism and belongs to the family of benzenes. The quantum yield for 5AHB has been measured at 1.4% in single molecule experiments and 4% in bulk experiments. The mechanistic studies have shown that it is a radiation sensitive compound with a short half life, which can be explained by its photolytic properties. 5AHB has also been shown to be an efficient photosensitizer, which can be used to generate singlet oxygen that can be used as an oxidizing agent or electron donor in photochemical reactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Tert-butyl 2-chloro-2-oxoacetate is a substrate analogue that has been shown to inhibit the activity of aminopeptidase (AP) and esterase (EST). These enzymes are important for the degradation of peptides in the urine. Tert-butyl 2-chloro-2-oxoacetate has also been shown to have antibacterial properties against uropathogenic E. coli. This analog interacts with substrate proteins, inhibiting their function, which leads to an increase in the concentration of substrates and an inhibition of bacterial growth. Tert-butyl 2-chloro-2-oxoacetate is an amide that can be used as a biomolecular probe for conformational studies and as an inhibitor for AP and EST.</p>

<p>5-Phenylpyridine-2-carbonitrile is a synthetic compound. It emits light when subjected to an electric field, and it can be used in intermolecular quantum efficiency measurements. 5-Phenylpyridine-2-carbonitrile has been shown to have a quantum efficiency of 0.72% in benzonitrile and picolinonitrile diodes at room temperature, which is lower than the quantum efficiency of phosphorescent materials such as ZnS:CuCl (0.87%). This may be due to the low energy required for the triplet state to emit light.</p>

<p>6-Phenylpyridine-2-carbonitrile is a nitrogenous organic compound that has been used as a ligand to bind metal ions. It is also an efficient aminating agent. 6-Phenylpyridine-2-carbonitrile binds to bidentate ligands such as imidazole, which leads to the formation of amides and nitriles. This product has been used in the synthesis of biomolecules with nitrogen, such as urea.</p>

<p>6-Phenylnicotinonitrile is a reactive moiety that is generated from the reaction of an aryl halide and boronic acid. The 6-phenyl group can be used to form new carbon-carbon bonds in the synthesis of heteroaromatic compounds. This compound can also be recycled after use by reacting it with a boronic acid, which creates another reactive moiety. This recycling process has been shown to increase the efficiency of this chemical reaction.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Diethylamino)-2,2-dimethyl-propan-1-ol is a psychoactive substance that belongs to the group of phenethylamines. It is structurally related to the precursor molecule 2,5-dihydroxyphenethylamine (or dopamine). 3-(Diethylamino)-2,2-dimethyl-propan-1-ol has been shown to inhibit cytochrome P450 2C19 and metabolize into glucuronidated metabolites through CYP3A4 and other isoforms. This metabolite is excreted in human urine as a result of its metabolism by uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Methyl N-(3-methylphenyl)carbamate is a methylating agent that can be used to modify the epigenome. It is an inhibitor of histone lysine demethylases, which are enzymes that remove methyl groups from the amino acid lysine on histones. Methyl N-(3-methylphenyl)carbamate can also inhibit DNA replication and actin filament formation. This drug has been shown to have a clastogenic effect in mammalian cells and is also an inhibitor of effector proteins.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-Ethyl-6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one is a chemical compound containing an iodide group and a nitrogen atom. Iodides can be formed by the iodocyclization of ethyl acetoacetate with ethyl iodide. The resulting 5-ethyl-6-methylpyrimidinecarboxylic acid can be converted to the desired product by treatment with potassium hydroxide in ethanol.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-(Mercaptomethyl)benzoic acid is a thiosemicarbazide derivative that has been used as a photosensitizer in photodynamic therapy. This compound has the ability to bind to selenide ions, which are electron acceptors, and is converted to its reactive form by light. 4-(Mercaptomethyl)benzoic acid may be used for the treatment of cancers that have been resistant to other treatments. The compound also shows potential for use in diagnosing or treating other conditions such as carboxylate ligand transfer reactions and cadmium toxicity. The diameter of this drug is around 2 nm.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-Formyl-5-iodobenzoic acid is a chemical compound that is used as a linker between small molecules. It has been shown to inhibit the activity of protein kinase and can be used in medicinal chemistry to validate new structures. The molecule is also an ether, which means it will react with chlorine gas to form a chloride ion. This reaction can be photocleaved, meaning the photolysis of the ether will lead to cleavage of the ether bond. 3-Formyl-5-iodobenzoic acid has a chemical structure that encodes for ether properties, which may be due to its ability to undergo photochemical reactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromo-4-chloropyridine-3-carboxaldehyde is a synthetic compound that has been shown to inhibit the kinase activity of the tyrosine kinase receptor, a protein that regulates cell growth and differentiation. It was developed as a potential treatment for autoimmune diseases, including erythematosus and rheumatoid arthritis. This drug has been studied in clinical trials as an oral agent with good pharmacokinetic properties and was found to be safe and well tolerated at doses up to 1000mg per day. These studies have shown promising results in early phase 2 clinical trials.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>TMP195 is a small molecule that inhibits the acetylation of histone H3 at lysine 9 (H3K9) and histone H4 at lysine 12 (H4K12). TMP195 has been shown to reduce the growth of metastatic colorectal cancer cells in vivo. It also inhibits tumor growth by decreasing the expression of colony-stimulating factor, which is involved in cell proliferation and differentiation. TMP195 may be used as a therapeutic agent for the treatment of cancers such as breast, lung, prostate, colon, and pancreas.</p>